Molecular Strategies to Engineer Transgenic Rice Seed Compartments for Large-Scale Production of Plant-Made Pharmaceuticals
The use of plants as bioreactors for the large-scale production of recombinant proteins has emerged as an exciting area of research. The current shortages in protein therapeutics due to the capacity and economic bottlenecks faced with modern protein production platforms (microbial, yeast, mammalian) has driven considerable attention towards molecular pharming. Utilizing plants for the large-scale production of recombinant proteins is estimated to be 2–10% the cost of microbial platforms, and up to 1,000-fold more cost effective than mammalian platforms (Twyman et al. Trends Biotechnol 21:570–578, 2003; Sharma and Sharma, Biotechnol Adv 27:811–832, 2009). In order to achieve an economically feasible plant production host, protein expression and accumulation must be optimized. The seed, and more specifically the rice seed has emerged as an ideal candidate in molecular pharming due to its low protease activity, low water content, stable protein storage environment, relatively high biomass, and the molecular tools available for manipulation (Lau and Sun, Biotechnol Adv 27:1015–1022, 2009).
- 实验82 植物缺水程度的鉴定(脯氨酸法)
- TEnest 2.0: Computational Annotation and Visualization of Nested Transposable Elements
- 组织培养培养基的灭菌与保存
- In Silico Methods for Identifying Organellar and Suborganellar Targeting Peptides in Arabidopsis Chloroplast Proteins and for Pr
- Protein Body Induction: A New Tool to Produce and Recover Recombinant Proteins in Plants
- Quantifying 13C-labeling in Free Sugars and Starch by GC-MS
- 皮尔逊金铃
- A Chemical Genetics Method to Uncover Small Molecules for Dissecting the Mechanism of ABA Responses in Arabidopsis Seed Germinat
- Micropropagation Systems of Feijoa (Acca sellowiana (O. Berg) Burret)
- Production of Transgenic Rice (Oryza sativa subspecies japonica cv. Taipei 309)